http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JO-3388-B1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f7ddc4774cf5f8a0bda44a780d73c53d
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2121-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2018
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2027
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2059
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2866
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-495
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4965
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2013
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4858
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4808
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2095
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4704
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4833
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4704
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4965
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-495
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-12
filingDate 2013-01-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2019-03-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4261199198699dc891ad2fab4db11ceb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fe40d3a69c3593b2a84cd0569c88cf0a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_88f818617155fc711072356aaa1f7fe0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d42d8ade151e2ef434d05c1fb7617e70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d5d4f1301eae7eb3f4cc20a0bc853336
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1cab2d6a4037a3d63658e92db75d58ca
publicationDate 2019-03-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JO-3388-B1
titleOfInvention A fixed-drug combination for oral administration that includes levocetirizine or a salt thereof is pharmacologically acceptable, and mentolukast or a salt thereof is pharmacologically acceptable.
abstract The present invention relates to a medicinal composition administered orally to inhibit or treat allergic rhinitis or asthma, and comprise: (a) a first particle fraction comprising levocetirizine or a pharmaceutically acceptable salt thereof and an organic acid, and (b) a second particle fraction comprising montelukast or its salt Medically acceptable. The pharmacological composition according to the present invention includes an organic acid as a stabilizing agent which can effectively inhibit the compound of the substances related to levocetirizine and montelukast. Thus, this compound shows good stability.
priorityDate 2012-01-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419504142
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1549000
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419504776
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5281040

Total number of triples: 54.